Inhibition of the release of mediators of immediate-type allergy in vivo and in vitro.
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D000707:Anaphylaxis; D000818:Animals; D000906:Antibodies; D000941:Antigens; D001249:Asthma / Q000517:prevention & control; D001491:Basophils; D002250:Carbon Radioisotopes; D004205:Cromolyn Sodium / Q000494:pharmacology; D005260:Female; D006634:Histamine H1 Antagonists; D006636:Histamine Release; D006639:Histidine / Q000378:metabolism; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000188:drug therapy*; D007073:Immunoglobulin E; D007545:Isoproterenol / Q000494:pharmacology; D008213:Lymphocyte Activation; D008297:Male; D008407:Mast Cells; D008875:Middle Aged; D008925:Mites; D008954:Models, Biological
D000318:Adrenergic beta-Agonists; D000906:Antibodies; D000941:Antigens; D002250:Carbon Radioisotopes; D006634:Histamine H1 Antagonists; D007073:Immunoglobulin E; D006639:Histidine; D007545:Isoproterenol; D004205:Cromolyn Sodium